Safeblood Bioanalytica was succesfully participated in the “Genomic Medicine in the Mediterranean GM2” conference that took place in Heraklion, Crete from 2-5 Oct 2013.
The conference dealt with the contribution of next generation technologies to genetic research, whilst the participants included students and young researchers from all over the world.
Our company represented “illumina” with a respective lecture on the future plans of illumina in clinical research.
More information you can find on the links http://www.gm2conferences.com and www.illumina.com.